Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

November 18, 2025

Study Completion Date

November 18, 2025

Conditions
Arteriovenous Fistula
Interventions
DEVICE

Covera Vascular Covered Stent

This is a single-arm study. All subjects will receive the Covera Vascular Covered Stent

Trial Locations (11)

27610

North Carolina Nephrology, Raleigh

48507

Michigan Vascular Center, Flint

55112

Minnesota Vascular and Surgery Center, New Brighton

55455

University of Minnesota Medical Center, Minneapolis

60559

Chicago Access Care, Westmont

75208

Dallas Renal Group, Dallas

78216

San Antonio Kidney and Disease Access Center, San Antonio

85012

Arizona Kidney Disease and Hypertension Center Medical Research Services, Phoenix

06511

Yale University, New Haven

01089

Kidney Care & Transplant Services of New England, West Springfield

02906

Providence Access Care, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY